Handbook of Contemporary Neuropharmacology
Copyright © 1999-2014 by John Wiley and Sons, Inc. All Rights Reserved.
Online ISBN: 9780470101001
Editors & Contributors
About the editors:
David Sibley is the Chief of the Molecular Neuropharmacology Division of the National Institute of Neurological Disorders and Health/NIH. His laboratory is currently investigating the molecular, cellular and biochemical properties of dopamine receptors and their role in neuronal signaling.
Israel Hanin is Professor and Chair Emeritus at the Department of Pharmacology at Loyola University Chicago. He formerly worked at the National Institute of Mental Health, Laboratory of Preclinical Pharmacology, and at the University of Pittsburgh Department of Psychiatry (WPIC). Dr. Hanin's laboratory focus has been on cholinergic mechanisms, animal models for Alzheimer's Disease, and the potential role of glycosaminoglycans in the treatment of Alzheimer's Disease.
Michael Kuhar was a member of the Neuroscience Department at Johns Hopkins and served in the Pharmacology Department as well. He also worked for the National Institute on Drug Abuse. Currently at Emory University, Dr. Kuhar has published more than 800 articles, abstracts, book chapters, reviews, and patents.
Phil Skolnick is the Vice President, Research and Chief Scientific Officer for DOV Pharmaceuticals. He is also a former Senior Investigator and Chief, Laboratory of Neuroscience, at the National Institutes of Health.